Skip to main content

Table 2 Characteristics of patients with and without early VA failure

From: Factors associated with early failure of vascular access in acute-phase patients

Parameter Without failure (n = 382) With failure (n = 53) P value
Age (years) 66.9 ± 14.6 70.7 ± 15.6 0.0819
Male (%) 65.2 49.1 0.0225*
Diabetes (%) 45.0 52.8 0.2854
Hypertension (%) 68.3 62.3 0.3770
Atrial fibrillation (%) 8.3 15.1 0.1128
Primary cause of admission
 Exacerbation of CRF (%) 64.1 54.7 0.1832
 Heart disease (%) 13.6 17.0 0.5081
 Heart failure (%) 9.9 15.1 0.2535
 Coronary artery disease (%) 2.4 1.9 0.8309
 Infectious disease (%) 6.5 9.4 0.4366
 Malignancy (%) 3.4 3.8 0.8898
 Cephalopathy (%) 2.6 3.8 0.6302
 Cerebral infarction (%) 0.5 1.9 0.2611
 Intracranial hemorrhage (%) 1.0 0.0 0.4542
 Peripheral artery disease (%) 0.5 1.9 0.2611
 Aortic disease (%) 1.0 0.0 0.4542
 Others (%) 8.1 9.4 0.7440
Warfarin (%) 9.7 11.3 0.7086
Antiplatelet agent (%) 31.2 32.1 0.8919
Statin (%) 32.2 30.2 0.7687
ACEi or ARB (%) 46.9 41.5 0.4642
Beta blocker (%) 34.0 34.0 0.9921
CCB (%) 60.0 60.4 0.9523
LVEF (%) 55.6 ± 12.9 56.5 ± 12.7 0.7022
SBP (mmHg) 138.6 ± 24.2 132.1 ± 23.7 0.0671
DBP (mmHg) 75.1 ± 16.2 69.1 ± 17.3 0.0119*
WBC (103/μL) 7.2 ± 3.2 8.0 ± 3.5 0.0870
Hb (g/dL) 9.8 ± 1.7 9.7 ± 1.9 0.6712
PLT (104/μL) 19.2 ± 7.8 19.7 ± 8.3 0.6834
TP (g/dL) 6.1 ± 0.9 5.9 ± 1.0 0.1570
ALB (g/dL) 3.0 ± 0.6 2.7 ± 0.8 0.0002**
BUN (mg/dL) 68.5 ± 28.7 63.0 ± 34.2 0.2035
Cr (mg/dL) 7.3 ± 3.0 6.4 ± 2.4 0.0414*
eGFR (mL/min/1.7 m2) 7.3 ± 3.9 7.6 ± 3.6 0.6209
AST (IU/L) 23.2 ± 20.0 25.8 ± 24.9 0.3891
ALT (IU/L) 18.9 ± 21.3 17.7 ± 21.4 0.7076
CRP (mg/dL) 2.2 ± 3.3 3.2 ± 4.4 0.0390*
APTT 30.2 ± 9.7 31.2 ± 8.1 0.5918
PT-INR 1.16 ± 0.40 1.16 ± 0.20 0.9994
AVF (%) 77.5 66.0 0.0671
  1. VA vascular access, CRF chronic renal failure, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, LVEF left ventricular ejection fraction, SBP systolic blood pressure, DBP diastolic blood pressure, WBC white blood cell, Hb hemoglobin, PLT platelet, TP total protein, ALB albumin, BUN blood urea nitrogen, Cr creatinine, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT alanine transaminase, CRP C-reactive protein, APTT activated partial thromboplastin time, PT-INR international normalized ratio of prothrombin time, AVF, arteriovenous fistula
  2. *P < 0.05; **P < 0.01